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Polymerases with other Roles 
η Somatic hypermutation
ζ Midgestation lethality in REV3L 
null mice; somatic hypermutation
λ Mice knockout has immotile cilia 
syndrome
ι Controversial role in somatic 
hypermutation and meiosis
θ Putative role in somatic 
 hypermutation
γ Defects in POLG associated with 
progressive external ophthal-
moplegia, Alpers syndrome, 
ataxia-neuropathy, Charcot-
Marie-Tooth disease, idiopathic 
Parkinson’s, and increased 
 toxicity in response to nucleo-
side reverse transcriptase inhibi-
tors. (For complete list, see: 
http://tools.niehs.nih.gov/polg/.)
Properties of DnA Template-Directed Mammalian DnA Polymerases
Polymerase family Human Gene function Additional Activities Mutation Rate Interactionsa
α B POLA Priming RNA primase 10−4–10−5 SMC1A
β X POLB Base excision repair dRP/AP lyase/termi-
nal transferase
10−4–10−5 TAF1D
γ A POLG Mitochondrial maintenance 3′→5′ exonuclease/
dRP lyase
10−5–10−6 POLG2, TWINKLE
δ B POLD1 Replicative polymerase; repair and 
mutagenesis
3′→5′ exonuclease 10−6–10−7 ABL1, FYN, GRB2, 
PCNA, POLD2, POLD4, 
PTP4A3, SRC
ε B POLE1 Replicative polymerase 3′→5′ exonuclease 10−6–10−7 TOPBP1/RAD17
ζ B REV3L Translesion DNA synthesis and 
chromosome stability 
10−4–10−5 MAD2L2, REV1
η Y POLH Translesion DNA synthesis 10−2–10−3 PCNA, Ubiquitin, 
RAD6/18, POLI
θ A POLQ Translesion DNA synthesis and 
chromosome stability
DNA-dependent 
ATPase/dRP lyase
10−2–10−3
ι Y POLI Translesion DNA synthesis dRP lyase 10−1 REV1, POLH, PCNA
κ Y POLK Translesion DNA synthesis  and 
nucleotide excision repair
10−2–10−3 PCNA, Ubiquitin, REV1
λ X POLL Nonhomologous end joining and 
meiosis
dRP lyase 10−4–10−5 PCNA
μ X POLM Nonhomologous end joining Terminal  transferase 10−4–10−5
ν A POLN Translesion DNA synthesis 10−3
REV1 Y REV1 Translesion DNA synthesis dCTP transferase MAD2L2, POLH, POLI, 
POLK, REV3, Ubiquitin
Mammalian Polymerases with Putative Roles in cancer
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Polymerase cancer Type supporting evidence
η Various; Xeroderma 
pigmentosa variant
Xeroderma pigmentosa variant cells are POLH− resulting in 
a greater susceptibility to sunlight-induced carcinomas
κ Lung Overexpression attributed to genetic instability
β Various Overexpression in various tumor types/increased 
 aneuploidy
θ Various Overexpression contributes to tumor progression
ι Breast, Lung Overexpression in human breast cancer lines; defective 
mouse allele results in susceptibility to urethane-induced 
lung tumors
ζ Colon REV3/REV7 expression levels linked to colon cancer
δ Epithelial Mouse POLD1 mutation (proofreading defi cient) results in 
several tumor types
In
d
ir
ec
t 
Li
nk
s Polymerase supporting evidence
REV1 Colocalizes with FANCD2 in HeLa cells; mutagenesis requires Fanconi anemia core 
complex
λ Nonhomologous end-joining defects linked to cancer
aInteractions from 
http://www.uniprot.org.
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DNA polymerases ensure the faithful duplication of genetic information inside the nuclease and mitochondria of eukaryotic cells and the nucleoid of prokaryotic cells. These 
remarkable enzymes synthesize polynucleotide chains based on the complementarity of an incoming nucleotide to an existing DNA template. DNA polymerases are grouped into 
six families (A, B, C, D, X, and Y). The previous SnapShot (DNA Polymerases I Prokaryotes) described the structural and functional characteristics conserved across the families, 
using the DNA polymerases from the bacterium Escherichia coli as an example. In this SnapShot, we now highlight DNA polymerases from humans (Homo sapiens) and their 
relationship to human diseases. However, this list is certainly not exhaustive, and the number of putative links between DNA polymerases and diseases continues to grow.
Mammalian DNA Polymerases
Mammalian cells use 14 DNA polymerases from the A, B, X, and Y families to replicate a variety of DNA substrates. These include two polymerases (δ and ε) to replicate the 
genome; a primase (α) to generate short strands of RNA for the initiation of DNA replication; a mitochondrial polymerase (γ) to replicate the mitochondrial genome; and several 
other polymerases that are necessary during the repair of damaged DNA (β, λ, and µ) or replication past DNA lesions (θ, ζ, η, ι, κ, ν, and Rev1). Many of these polymerases pos-
sess additional enzymatic activities that enhance their ability to perform specialized functions. For example, the replicative polymerases (γ, δ, and ε) contain 3′ to 5′ exonuclease 
activity. In addition, many of the DNA repair polymerases (β, θ, ι, and λ) help to remove damaged nucleotides during base excision repair (BER) via abasic site lyase (AP lyase) 
and/or 5′ deoxyribose-5-phosphate lyase (dRP lyase) activities.
DNA Polymerases in Human Disease
Although the health and survival of the organism relies on the proper activity of each DNA polymerase, their specialized functions also come at a potential cost to the organism, 
including an increased susceptibility to cancer. For example, tumor formation has been associated with the inactivation or overexpression of the Y family of DNA polymerases, 
η and κ, respectively. These polymerases preferentially catalyze the duplication of damaged substrates, which the replicative polymerases (δ and ε) are unable to copy. To 
accomplish this task, the Y family polymerases contain an open, spacious active site that makes few contacts with template DNA and incoming nucleotides. This allows bulky 
DNA lesions to fit inside their active site, but it also results in lower fidelity (mutation rates ?10−1–10−4) compared to the replicative DNA polymerases δ and ε, which have compact 
active sites (mutation rates ?10−6–10−7). Therefore, the cell must tightly regulate the expression and activity of these low-fidelity polymerases (η, ζ, ι, θ, ν, and κ) to ensure that 
their beneficial activity is directed to the proper substrates during translesion synthesis, somatic hypermutation, and meiosis. Current research is aimed at deciphering the com-
plex regulation of these polymerases, which appears to occur via modulation of protein levels, posttranslational modifications of the enzymes, and a variety of protein-protein 
interactions. Without these proper controls, cells are more susceptible to tumor formation.
Improper activity of high-fidelity polymerases, such as β and δ from the X and B families, can also result in an increased susceptibility to cancer. Moreover, other types of DNA 
polymerases are indirectly associated with tumor formation through their critical role in genome maintenance pathways. For example, the nonhomologous end-joining (NHEJ) 
pathway, which repairs double-stranded breaks in DNA, is associated with cancer, but the polymerases involved in these pathways, such as λ and µ, have not been directly 
linked. In general, the stability of an organism’s genome requires a full complement of properly regulated DNA polymerases to avoid tumor formation.
In addition to preventing cancer, many other aspects of mammalian health depend on the proper function and regulation of DNA polymerases. For example, numerous 
disorders, such as progressive external ophthalmoplegia and idiopathic Parkinson’s disease, result from the improper activity of the mitochondrial DNA polymerase γ. DNA 
polymerases also have potential links to embryonic development (ζ) and respiratory function (λ).
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